Trademarkia Logo

Canada

C$
Trademark Search in Canada
GEMREVO

View On IC.GC.CA

GEMREVO
APPROVED

on 18 Apr 2025

Last Applicant/ Owned by

Merck KGaA

Frankfurter Str. 25064293 Darmstadt

DE

Serial Number

2250452 filed on 9th Mar 2023

Correspondent Address

SMART & BIGGAR LP

SUITE 1000, 55 METCALFE STREETP.O. BOX 2999, STATION DOTTAWA

ONTARIO

CA

K1P5Y6

GEMREVO

Trademark usage description

pharmaceutical products, namely, pharmaceutical preparations for use in the treatment of immunological diseases and disorders, pharmaceutical preparat Read More

Classification Information

Class [005]
Pharmaceutical products, namely, pharmaceutical preparations for use in the treatment of immunological diseases and disorders, pharmaceutical preparations for the treatment of neurological diseases and disorders, namely, Multiple sclerosis, Lupus erythematosus, Myasthenia gravis, Alzheimer's, Huntington's Disease, cerebral palsy, brain injury, spinal cord injury, seizure disorders, and pharmaceutical preparations for the treatment of immunological diseases and disorders, namely inflammatory bowel diseases, inflammatory connective tissue diseases, inflammatory pelvic diseases.

Classification kind code

12

Mark Details

Serial Number

2250452

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 22
on 11th Jul 2024		Search Recorded
Submitted for opposition 20
on 11th Jul 2024		Examiner's First Report
Submitted for opposition 256
on 22nd Apr 2024		Notification of Possible Opposition Sent
Submitted for opposition 257
on 22nd Jun 2023		Designation Notification - Madrid Protocol
Submitted for opposition 210
on 22nd Jun 2023		IR Correction
Submitted for opposition 257
on 6th Apr 2023		Designation Notification - Madrid Protocol
Submitted for opposition 1
on 5th Apr 2023		Created
Submitted for opposition 31
on 5th Apr 2023		Formalized
Submitted for opposition 228
on 9th Mar 2023		International Registration
Submitted for opposition 30
on 9th Mar 2023		Filed